Characteristics of patients with staghorn calculi in our experience

International Journal of Urology

Volumn 11, Issue 5, 2004, Pages 276-281

  Akagashi, Keigo ^a,b   Tanda, Hitoshi ^a   Kato, Shuji ^a   Ohnishi, Shigeki ^a   Nakajima, Hisao ^a   Nanbu, Akihito ^a   Nitta, Toshikazu ^a   Koroku, Mikio ^a   Sato, Yoshikazu ^a   Hanzawa, Tatsuo ^a  

^a Sanjukai Hospital   (Japan)

^b 003 0002 Sanjukai Hospital   (Japan)

Author keywords

Hypercalciuria; Immobilization; Staghorn calculus; Urinary tract infection

Indexed keywords

AMMONIUM MAGNESIUM PHOSPHATE; CALCIUM OXALATE; CALCIUM OXALATE PHOSPHATE; CALCIUM PHOSPHATE; STRUVITE; UNCLASSIFIED DRUG; URIC ACID;

ADULT; AGED; CALCIUM STONE; CLINICAL FEATURE; CYSTINURIA; DAILY LIFE ACTIVITY; DISABILITY; FEMALE; HUMAN; HYPERCALCIURIA; HYPERURICEMIA; INDWELLING CATHETER; KIDNEY MALFORMATION; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; RANKIN SCALE; RATING SCALE; REVIEW; STAGHORN STONE; STONE ANALYSIS; STRUVITE STONE; URIC ACID STONE; URINARY TRACT INFECTION; URINE CULTURE; URINE PH; UROLITHIASIS;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; CALCIUM; CALCIUM OXALATE; CALCIUM PHOSPHATES; CATHETERS, INDWELLING; CYSTINURIA; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; HYPERURICEMIA; KIDNEY; KIDNEY CALCULI; MAGNESIUM COMPOUNDS; MALE; MIDDLE AGED; PHOSPHATES; RETROSPECTIVE STUDIES; URIC ACID; URINARY TRACT INFECTIONS; URINE;

EID: 2942560589     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2004.00800.x     Document Type: Review

References (17)

1. Segura JW. Staghorn calculi. Urol. Clin. North Am. 1997; 24: 71-80.
2. Vargas AD, Bragin SD, Mendez R. Staghorn calculus: Its clinical presentation, complications and management. J. Urol. 1982; 127: 860-2.
3. Teichman JMH, Long RD, Hulbert JC. Long-term renal fate and prognosis after staghorn calculus management. J. Urol. 1995; 153: 1403-7.
4. Yamamoto H, Hiraishi K, Kurokawa K. Clinical observation of staghorn calculi. 1. Statistical analysis. Nippon Hinyoukika Gakkai Zasshi 1982; 73: 752-8.
5. Koga S, Arakaki Y, Matsuoka M, Ohyama C. Staghorn calculi-Long-term results of management. Br. J. Urol. 1991; 68: 122-4.
6. Miyake O, Tsujihata M, Itoh H, Wakatsuki A, Itatani H. Treatment of staghorn calculi-ESWL monotherapy. Hinyoukika Kiyou 1993; 39: 1081-5.
7. Yasumoto R, Sakakura T, Yamamoto K, Sugimoto T, Wada S, Kishimoto T. Treatment of staghorn calculi by extracorporeal shock wave lithotripsy monotherapy. Hinyoukika Kiyou 1993; 39: 1093-5.
8. Gettman MT, Segura JW. Struvite stones: Diagnosis and current treatment concepts. J. Endourol. 1999; 13: 653-8.
9. Rankin J. Cerebral vascular accidents in patients over the age of 60. 2. Prognosis. Scott. Med. J. 1957; 2: 200-215.
10. Resnik MI. Evaluation and management of infection stones. Urol. Clin. North Am. 1981; 8: 265-76.
11. Saad F, Paquin J-M, Faucher R., Perreault J-P, Mauffette F, Valiquette L. Staghorn calculi treated by percutaneous nephrolithotomy: Risk factors for recurrence. Urology 1993; 41: 141-3.
12. Comarr AE. A long-term survey of the incidence of renal calculosis in paraplegia. J. Urol. 1955; 74: 447-52.
13. Miyazaki F, Miyahara S, Matsuoka K, Noda S, Eto K, Nakamura Y, Takagi K. Clinical study of urinary stones in immobilized patients. Nishinippon Hinyoukika 1989; 51: 1495-8.
14. Yoshida O, Okada Y. Epidemiology of urolithiasis in Japan: a chronological and geographical study. Urol. Int. 1990; 45: 104-11.
15. Resnik MI, Boyce WH. Bilateral staghorn calculi-patient evaluation and management. J Urol. 1980; 123: 338-41.
16. Wall I, Hellgren E, Larsson L, Tiselius H-G. Biochemical risk factors in patients with renal staghorn stone disease. Urology 1996; 28: 377-80.
17. Yoshida O, Terai T, Ohkawa T, Okada Y. National trend of the incidence of urolithiasis in Japan. Kidney International 1999; 56: 1899-904.